Special items: Ovarian Cancer and Us blog best viewed in Firefox

Friday, May 06, 2011

abstract: The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer

"While literature for the association between ET and CRC risk is heterogeneous, our analyses suggest only current use of ET is associated with a decreased CRC risk."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.